Atavistik Bio

About Atavistik Bio

Atavistik Bio is a biotechnology company focused on revolutionizing the discovery of precision allosteric small molecule therapeutics. Their mission is to address serious unmet patient needs by unlocking novel allosteric binding pockets and advancing structural insights into drug design using their proprietary AMPS platform.

Products & Services

Precision Allosteric Small Molecules:Therapeutics designed to offer transformative treatment options for patients across a broad range of diseases, with a focus on precision oncology and rare diseases.

AMPS Platform:A proprietary drug discovery platform that combines computational and experimental techniques to identify functional allosteric pockets for efficient drug design across various target classes.

Specialties

Precision Oncology Rare Diseases Allosteric Small Molecule Therapeutics Drug Discovery Platform (AMPS) precision allosteric small molecules allosteric drug discovery precision oncology rare diseases

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 40000000 MR: - FA: 40 million FAN: 40000000	D: 2026-03-05 FD: 2026-03-05	5 investors
2	RT: Series B T: - FT: Series B	A: 120000000 MR: - FA: $120 million FAN: 120000000	D: 2025-12-18 FD: 2025-12-18	4 investors
3	RT: Additional Financing T: - FT: Additional Financing	A: 40000000 MR: - FA: $40 million FAN: 40000000	D: 2023-12-19 FD: 2023-12-19	3 investors

Series B Latest

2026-03-05

$40.0M

5 investors (Pro only)

Series B 2025-12-18

$120.0M

Additional Financing 2023-12-19

$40.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bryan E. Stuart

Chief Executive Officer

M

Marion Dorsch

President and Chief Scientific Officer

P

Paul Bruno

Chief Business Officer

S

Susan Pandya

Chief Medical Officer

M

Maria-Jesus Blanco

Senior Vice President, Head of Drug Discovery

P

Patrick McNamara

Senior Vice President, Clinical Operations

View 20 more team members with Pro

Unlock Full Team Directory

Recent News

Atavistik Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised